Tripentones: A Promising Series of Potent Anti-Cancer Agents

ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)

Volume 17, 14 Issues, 2017

Download PDF Flyer

Anti-Cancer Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Anti-Cancer Agents

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 27th of 59 in Chemistry, Medicinal

Submit Abstracts Online Submit Manuscripts Online

Michelle Prudhomme
Institut de Chimie de Clermont-Ferrand
Université Clermont Auvergne

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.722
5 - Year: 2.849

Tripentones: A Promising Series of Potent Anti-Cancer Agents

Anti-Cancer Agents in Medicinal Chemistry, 9(4): 369-380.

Author(s): Christophe Rochais, Patrick Dallemagne and Sylvain Rault.

Affiliation: CERMN UPRES EA 4258–FR CNRS 3038 INC3M, UFR des Sciences Pharmaceutiques–Universite de Caen Basse-Normandie, Bd Becquerel 14032 Caen Cedex, France.


The 8H-thieno[2,3-b]pyrrolizinones, some of which exert very potent cytotoxic activity against tumor cell lines in vitro, are a promising novel series of anti-cancer agents. These compounds belong to the tripentone family and are based on 9H-pyrrolo[1,2-a]indol- 9-one derivatives and their heterocyclic isosteres. This paper inventories the different synthetic strategies for tripentones and reviews their biological effects and therapeutic potential.


Tripentone, pyrrolizinone, pyrroloindolone, thiophene, cancer.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 9
Issue Number: 4
First Page: 369
Last Page: 380
Page Count: 12
DOI: 10.2174/1871520610909040369
Price: $58
Global Biotechnology Congress 2017Drug Discovery and Therapy World Congress 2017

Related Journals

Related eBooks

Webmaster Contact: Copyright © 2017 Bentham Science